Evidence map›Paper›PMID 28726033›Full record

ArticleInternal and emergency medicine2017

Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin.

Raffaele Manna, Roberto Cauda, Sandro Feriozzi, Giovanni Gambaro, Antonio Gasbarrini, Didier Lacombe, Avi Livneh, Alberto Martini, Huri Ozdogan, Antonio Pisani and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Internal and emergency medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Screening for Fabry's disease in a high-risk subpopulation of FMF.European journal of medical research · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Raffaele MannaCentro di Ricerca delle Febbri Periodiche e Malattie Rare, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168, Rome, Italy. raffaele.manna@policlinicogemelli.it.
Roberto CaudaIstituto di Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
Sandro FeriozziDivision of Nephrology, Belcolle Hospital, Viterbo, Italy.
Giovanni GambaroDivisione di Nefrologia, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
Antonio GasbarriniDivisione di Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
Didier LacombeCHU Bordeaux, MRGM Laboratory, Department Medical Genetics, University of Bordeaux, Bordeaux, France.
Avi LivnehDepartment of Medicine, Sheba Medical Center, Tel Hashomer, Israel, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Alberto MartiniDivision of Rheumatology, Gaslini Foundation, Genoa, Italy.
Huri OzdoganDivision of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University Fatih, Istanbul, Turkey.
Antonio PisaniDepartment of Public Health, Naples, Italy.
Eleonora RiccioDepartment of Public Health, Naples, Italy.
Elena VerrecchiaCentro di Ricerca delle Febbri Periodiche e Malattie Rare, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168, Rome, Italy.
Lorenzo DagnaUnit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
International Panel for RAre recurrent FUO-IPRAFUO
Università Cattolica del Sacro Cuore · ITIstanbul University · TRTel Aviv University · ILUniversité de Bordeaux · FRVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fever of unknown origin (FUO) is a rather rare clinical syndrome representing a major diagnostic challenge. The occurrence of more than three febrile attacks with fever-free intervals of variable duration during 6 months of observation has recently been proposed as a subcategory of FUO, Recurrent FUO (RFUO). A substantial number of patients with RFUO have auto-inflammatory genetic fevers, but many patients remain undiagnosed. We hypothesize that this undiagnosed subgroup may be comprised of, at least in part, a number of rare genetic febrile diseases such as Fabry disease. We aimed to identify key features or potential diagnostic clues for Fabry disease as a model of rare genetic febrile diseases causing RFUO, and to develop diagnostic guidelines for RFUO, using Fabry disease as an example of inserting other rare diseases in the existing FUO algorithms. An international panel of specialists in recurrent fevers and rare diseases, including internists, infectious disease specialists, rheumatologists, gastroenterologists, nephrologists, and medical geneticists convened to review the existing diagnostic algorithms, and to suggest recommendations for arriving at accurate diagnoses on the basis of available literature and clinical experience. By combining specific features of rare diseases with other diagnostic considerations, guidelines have been designed to raise awareness and identify rare diseases among other causes of FUO. The proposed guidelines may be useful for the inclusion of rare diseases in the diagnostic algorithms for FUO. A wide spectrum of patients will be needed to validate the algorithm in different clinical settings.

Indexed as

AlgorithmsDiagnosis, DifferentialFabry DiseaseFever of Unknown OriginHumansRare DiseasesRecurrenceAlgorithmDiagnosisFabry diseaseFever of unknown originFUORare diseasesRecommendationsRecurrent fever of unknown originRFUO

Identifiers

PMID28726033
OpenAlexW2737002991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.